Standout Papers

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure 2024 202650
  1. Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure (2024)
    Zachary L. Cox, Sean P. Collins et al. Journal of the American College of Cardiology

Immediate Impact

15 standout
Sub-graph 1 of 8

Citing Papers

Global Public Health Burden of Heart Failure: An Updated Review
2023 Standout
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
2022 Standout
2 intermediate papers

Works of A. Thomas McRae being referenced

Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial
2020

Author Peers

Author Last Decade Papers Cites
A. Thomas McRae 105 31 11 69 45 10 156
Alastair Gray 68 40 7 42 24 11 189
Nayeon Ahn 71 73 3 91 58 10 240
Elizabeth Swiggum 119 19 3 29 53 11 188
Eva Turgonyi 127 20 2 46 22 11 184
F J Maritz 78 31 2 24 42 12 210
Eugene B. Reyes 225 30 52 24 8 250
Ata ur Rehman Quraishi 76 8 16 47 61 11 143
Mohamad Sinno 118 19 8 30 29 13 155
Benjamin M. Baker 89 19 5 22 47 9 246
Eugenio B Reyes 165 21 24 21 10 209

All Works

Loading papers...

Rankless by CCL
2026